The World Bank Working for a World Free of Poverty Microdata Library
  • Data Catalog
  • About
  • Collections
  • Citations
  • Terms of use
  • Login
    Login
    Home / Central Data Catalog / IMPACT_EVALUATION / BFA_2017_HRBFIE-FEL_V01_M / variable [F9]
impact_evaluation

Results-Based Financing Impact Evaluation Health Facility 2017, Endline Survey

Burkina Faso, 2017
Get Microdata
Reference ID
BFA_2017_HRBFIE-FEL_v01_M
DOI
https://doi.org/10.48529/01gp-gm52
Producer(s)
Manuela de Allegri, Herve Hien, Paul Jacob Robyn
Collection(s)
Impact Evaluation Surveys Fragility, Conflict and Violence
Metadata
Documentation in PDF DDI/XML JSON
Created on
Aug 27, 2019
Last modified
Oct 01, 2019
Page views
202353
Downloads
2612
  • Study Description
  • Data Description
  • Documentation
  • Get Microdata
  • Related datasets
  • Data files
  • f1_jul19
  • f1p_jul19
  • f1u_jul19
  • f2_jul19
  • f3_jul19
  • f4_jul19
  • f5_jul19
  • f6_jul19
  • f7_jul19

F7_220_M (f7_220_5)

Data file: f7_jul19

Overview

Valid: 147
Invalid: 0
Type: Discrete
Start: 717
End: 741
Width: 25
Range: -
Format: character

Questions and instructions

Categories
Value Category Cases
0 8
5.4%
00 22
15%
2 2
1.4%
3 2
1.4%
4 1
0.7%
99 1
0.7%
ASL 2
1.4%
ASL inj 1
0.7%
ASL injec 1
0.7%
ASL+HPV 1
0.7%
Albendazol cp 1
0.7%
Amoxi 1
0.7%
Amoxi gel 1
0.7%
Amoxicilline 1
0.7%
Ampi 1g 1
0.7%
COMPRESSE A GAZE STERILES 1
0.7%
Ceftriaxone 1
0.7%
Cloxa gel 1
0.7%
Compresse 1
0.7%
Cotrimoxazole 1
0.7%
EXPECTORAL 1
0.7%
FAF 1
0.7%
Furosemid cp 1
0.7%
Gant 2
1.4%
HPR 1
0.7%
HPV 1
0.7%
HYDROCORTIXONE 1
0.7%
Hydrocortisone 1
0.7%
Hydrortisone 1
0.7%
Hydroxyde d'aluminium 1
0.7%
Ibuprifène, Betadine 1
0.7%
Ibuprofène comp 200mg 1
0.7%
Mebendazol 1
0.7%
Multivitamine cp 1
0.7%
PARACETAMOL 1
0.7%
Para 1
0.7%
Paracetamol 1
0.7%
Paracetamol comp 1
0.7%
Perfalgan inj 1
0.7%
Phliso 1
0.7%
Prunex pomade 1
0.7%
QUININE 1
0.7%
SERINGUE. GANT 1
0.7%
Seringue 5cc 1
0.7%
Sparadrap 2
1.4%
Sparadrap, ampi inj 1
0.7%
acide adcorbique 1
0.7%
albendazole 2
1.4%
albendazole sirop 1
0.7%
amoxiciline 1
0.7%
amoxiciline gel 1
0.7%
amoxicilline 4
2.7%
ampi 2
1.4%
ampi injec. seringue 5cc 1
0.7%
artesunate amodiaquine 1
0.7%
asl 2
1.4%
asl 900 1
0.7%
bande 2
1.4%
betadine 2
1.4%
butyl cp 1
0.7%
carbotoux sirop 1
0.7%
chlor 1
0.7%
chlor,para,amoxi,quinine 1
0.7%
compresse 1
0.7%
diasepam et metopimenzine 1
0.7%
diclo 1
0.7%
diclo injectable 1
0.7%
diclofenac 2
1.4%
gant 1
0.7%
gants 2
1.4%
glucosé isotonique 1
0.7%
h 1
0.7%
hpv, ASL 1
0.7%
hydrocortisone inj 1
0.7%
hydroxide 1
0.7%
ibuprofene 1
0.7%
implants 1
0.7%
mag 2 1
0.7%
metro ovule 1
0.7%
metronidazole 1
0.7%
mucanazole 1
0.7%
para 1
0.7%
paracetamol 3
2%
paracetamol comp 1
0.7%
perfalgan 2
1.4%
perfuseur 1
0.7%
phloro injectable 1
0.7%
phloroglucinole 1
0.7%
ploro 1
0.7%
ploroglycinol 1
0.7%
rien 1
0.7%
seringue 5
3.4%
seringue 10cc 1
0.7%
viscid gel 1
0.7%
vita c 1
0.7%
vitamine c 2
1.4%
Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.
Back to Catalog
The World Bank Working for a World Free of Poverty
  • IBRD IDA IFC MIGA ICSID

© The World Bank Group, All Rights Reserved.

This site uses cookies to optimize functionality and give you the best possible experience. If you continue to navigate this website beyond this page, cookies will be placed on your browser. To learn more about cookies, click here.